drugset / Trial / NCT06195137

Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)

NCT06195137

Completed 130 enrolled Lu Jiang
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study was to evaluate the efficacy of caffeine and alpha-lipoic acid in the treatment of burning mouth syndrome by symptom assessment with visual analogue scale.

Timeline

Start
2021-12-13
Primary completion
2023-06-15
Completion
2023-06-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator alpha-lipoic acid Small molecule 200 mg